
#31 – “Mind the Gap”: Antimicrobial Stewardship at Transitions of Care
Antimicrobial stewardship is often an inpatient effort and overlooked at transitions of care. Dr. April Dyer (@aprildyerid) and Dr. Rachel Kenney (@rkenneypharmd) share insight with host Dr. David Ha ...
20 Marras 20200s

#29 – What You May Have Missed Due to COVID-19: ID Literature Updates 2020 Part 2
Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) discuss notable infectious diseases publications from the first half of 2020. Papers discussed: 1) Van Duin D, et al. Lancet Infect Dis. ...
11 Syys 20201h 17min

#28 – What You May Have Missed Due to COVID-19: ID Literature Updates 2020 Part 1
Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) discuss notable infectious diseases publications from the first half of 2020! Papers discussed: 1) Rybak MJ, et al. Am J Health Syst Phar...
4 Syys 20201h 14min

#27 – Expert Updates in Gram Negative Resistance: Q&A Session
This is part 2 of a continuing education series produced in partnership with the SIDP Education Center (SIDPEC) on gram-negative bacterial resistance. It features expert speakers, Drs. Keith Kaye (@Ke...
31 Heinä 20201h 17min

#26 – OPAT - The Final Frontier, Part 2
Gain insight into Outpatient Parenteral Antibiotic Therapy (OPAT) practices across the country from Drs. Jessie Ortwine (@jkortwine), Monica Mahoney (@mmpharmd), Keenan Ryan (@keenanconazole), Monica ...
19 Kesä 202032min

#25 – Remdesivir: Ethical and Practical Considerations for Allocation, Tracking, and More
Drs. Julie Ann Justo (@julie_justo), Erin McCreary (@erinmccreary), and Helen Newland (@helennewland) discuss ethical allocation of Emergency Use Authorization remdesivir for patients with COVID-19. L...
18 Kesä 20201h 16min

#24 – OPAT – The Final Frontier, Part 1
Gain insight into Outpatient Parenteral Antibiotic Therapy (OPAT) practices across the country from Drs. Jessie Ortwine (@jkortwine), Monica Mahoney (@mmpharmd), Keenan Ryan (@keenanconazole), Monica ...
12 Kesä 202025min



















